This Government Contract opportunity from Department Of Defense was posted on May 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Manufacturing of Coagulation Quality Control Reagents
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract involves the manufacturing of MICCOAGULATION quality control reagents specifically designed for citrated blood samples. It requires the production of vials containing both normal and abnormal level solutions, which must comply with the technical specifications and stability criteria established by the Defense Logistics Agency (DLA). The contract is classified under NAICS code 325414 and is intended as a subcontract through the Department of Defense's Medical Supply Chain MD SURG FSF office. The work will be performed in Williamsburg, with the contract solicitation posted on May 11, 2026, and a response deadline set for May 18, 2026. The contract ensures that the produced reagents meet stringent quality and performance standards necessary for coagulation testing. No specific set-asides or organization types are indicated, and the contract details are accessible through the DLA's online bidding system.
General Info
Agency
NAICS
Place of Performance
WILLIAMSBURG, VA, 23185-5830, USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
